Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review
Journal of Clinical Medicine · 29.08.2025 · 14 (17) · 6119
DOI: 10.3390/jcm14176119 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.08.2025. Verfasst von John K Appiah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, PA 18711, USA. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inflammatory bowel disease (IBD), comprising Crohn’s disease (CD) and ulcerative colitis (UC), represents a significant challenge in gastroenterology due to its chronic nature, unpredictable course, and impact on patients’ quality of life. The therapeutic landscape for IBD has evolved significantly with the advent of biologic agents targeting specific immune pathways. However, limitations, including partial efficacy, side effects, and development of resistance, highlight the ongoing need for innovative treatment approaches. This review explores emerging therapies in IBD, including novel biologics, small molecules, microbiome-based therapies, and gene and stem cell therapies. The article summarizes their mechanisms of action, clinical efficacy, safety profiles, and potential future directions in IBD management. Methods: This comprehensive narrative review synthesizes current knowledge and emerging developments in inflammatory bowel disease (IBD) therapeutics. Literature was identified through targeted selection of high-quality sources, including pivotal randomized controlled trials, systematic reviews and meta-analyses, regulatory approval documents, and clinical practice guidelines from major gastroenterology societies. Emphasis was placed on recent publications (2020–2024) to capture the rapidly evolving therapeutic landscape, with particular attention to FDA/EMA-approved therapies and promising late-stage investigational agents. Sources were prioritized based on clinical relevance, study quality, and regulatory status. This narrative approach was selected to provide comprehensive coverage of diverse therapeutic modalities spanning conventional treatments to cutting-edge techniques, including biologics, small molecules, microbiome-based therapies, gene therapy, and stem cell treatments. The review acknowledges the inherent limitations of non-systematic literature selection while prioritizing clinical utility and educational value for healthcare providers managing IBD patients in contemporary practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, PA 18711, USA.
- Department of Internal Medicine, Tamale Teaching Hospital, Tamale NT2701, Ghana.
- Department of Internal Medicine, Division of Gastroenterology, Geisinger Health System, Danville, PA 18711, USA.
- Department of Gastroenterology, Advent Health, Orlando, FL 32803, USA.
- Department of Gastroenterology, Maimonides Medical Center, New York, NY 11219, USA.
ORCID-Profile: Nikita Garg, Muhammad U Haider
Zitieren
APA
Appiah, J. K., Hayat, U., Garg, N., Asante, R., Donneyong, E., Haider, M. U., Patel, P., Khan, Z., & Siddiqui, A. A. (2025). Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review. Journal of Clinical Medicine, 14(17), 6119. https://doi.org/10.3390/jcm14176119
Vancouver
Appiah JK, Hayat U, Garg N, Asante R, Donneyong E, Haider MU, et al. Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review. Journal of Clinical Medicine. 2025;14(17):6119. doi:10.3390/jcm14176119
BibTeX
@article{Appiah2025,
author = {Appiah, John K and Hayat, Umar and Garg, Nikita and Asante, Richeal and Donneyong, Evans and Haider, Muhammad U and Patel, Pranav and Khan, Zubair and Siddiqui, Ali A},
title = {Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {17},
pages = {6119},
doi = {10.3390/jcm14176119}
}
EUVIMED